These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 24805083)

  • 1. Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.
    Schutte RJ; Schutte SS; Algara J; Barragan EV; Gilligan J; Staber C; Savva YA; Smith MA; Reenan R; O'Dowd DK
    J Neurophysiol; 2014 Aug; 112(4):903-12. PubMed ID: 24805083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizure Phenotype and Underlying Cellular Defects in
    Roemmich AJ; Vu T; Lukacsovich T; Hawkins C; Schutte SS; O'Dowd DK
    eNeuro; 2021; 8(5):. PubMed ID: 34475263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients.
    Kim HW; Quan Z; Kim YB; Cheong E; Kim HD; Cho M; Jang J; Yoo YR; Lee JS; Kim JH; Kim YI; Kim DS; Kang HC
    Brain Dev; 2018 Apr; 40(4):287-298. PubMed ID: 29295803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A knock-in model of human epilepsy in Drosophila reveals a novel cellular mechanism associated with heat-induced seizure.
    Sun L; Gilligan J; Staber C; Schutte RJ; Nguyen V; O'Dowd DK; Reenan R
    J Neurosci; 2012 Oct; 32(41):14145-55. PubMed ID: 23055484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome.
    Cheah CS; Lundstrom BN; Catterall WA; Oakley JC
    J Neurosci; 2019 Nov; 39(46):9251-9260. PubMed ID: 31537705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice.
    Colasante G; Lignani G; Brusco S; Di Berardino C; Carpenter J; Giannelli S; Valassina N; Bido S; Ricci R; Castoldi V; Marenna S; Church T; Massimino L; Morabito G; Benfenati F; Schorge S; Leocani L; Kullmann DM; Broccoli V
    Mol Ther; 2020 Jan; 28(1):235-253. PubMed ID: 31607539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preictal dysfunctions of inhibitory interneurons paradoxically lead to their rebound hyperactivity and to low-voltage-fast onset seizures in Dravet syndrome.
    Capitano F; Kuchenbuch M; Lavigne J; Chaptoukaev H; Zuluaga MA; Lorenzi M; Nabbout R; Mantegazza M
    Proc Natl Acad Sci U S A; 2024 Jun; 121(23):e2316364121. PubMed ID: 38809712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication.
    Matricardi S; Cestèle S; Trivisano M; Kassabian B; Leroudier N; Vittorini R; Nosadini M; Cesaroni E; Siliquini S; Marinaccio C; Longaretti F; Podestà B; Operto FF; Luisi C; Sartori S; Boniver C; Specchio N; Vigevano F; Marini C; Mantegazza M
    Epilepsia; 2023 May; 64(5):1331-1347. PubMed ID: 36636894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype associations in 1018 individuals with SCN1A-related epilepsies.
    Gallagher D; Pérez-Palma E; Bruenger T; Ghanty I; Brilstra E; Ceulemans B; Chemaly N; de Lange I; Depienne C; Guerrini R; Mei D; Møller RS; Nabbout R; Regan BM; Schneider AL; Scheffer IE; Schoonjans AS; Symonds JD; Weckhuysen S; Zuberi SM; Lal D; Brunklaus A
    Epilepsia; 2024 Apr; 65(4):1046-1059. PubMed ID: 38410936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCN1A mutation spectrum in a cohort of Bulgarian patients with GEFS+ phenotype.
    Peycheva V; Ivanova N; Kamenarova K; Panova M; Pacheva I; Ivanov I; Bojidarova M; Tacheva G; Stamatov D; Litvinenko I; Hristova D; Deneva D; Rodopska E; Slavkova E; Aleksandrova I; Simeonov E; Dimova P; Bojinova V; Mitev V; Jordanova A; Kaneva R
    Turk J Pediatr; 2020; 62(5):711-725. PubMed ID: 33108073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation spectrum of the SCN1A gene in a Hungarian population with epilepsy.
    Till Á; Zima J; Fekete A; Bene J; Czakó M; Szabó A; Melegh B; Hadzsiev K
    Seizure; 2020 Jan; 74():8-13. PubMed ID: 31765958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological Alterations of Pyramidal Cells and Interneurons of the CA1 Region of the Hippocampus in a Novel Mouse Model of Dravet Syndrome.
    Dyment DA; Schock SC; Deloughery K; Tran MH; Ure K; Nutter LMJ; Creighton A; Yuan J; Banderali U; Comas T; Baumann E; Jezierski A; ; Boycott KM; Mackenzie AE; Martina M
    Genetics; 2020 Aug; 215(4):1055-1066. PubMed ID: 32554600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
    Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
    J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A selective Na
    Chow CY; Chin YKY; Ma L; Undheim EAB; Herzig V; King GF
    Biochem Pharmacol; 2020 Nov; 181():113991. PubMed ID: 32335140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenotype and SCN1A gene mutation screening in 39 families with generalized epilepsy with febrile seizures plus].
    Xu XJ; Zhang YH; Sun HH; Liu XY; Wu HS; Wu XR
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):580-6. PubMed ID: 23158734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium channel SCN1A and epilepsy: mutations and mechanisms.
    Escayg A; Goldin AL
    Epilepsia; 2010 Sep; 51(9):1650-8. PubMed ID: 20831750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome.
    Tiraboschi E; Martina S; van der Ent W; Grzyb K; Gawel K; Cordero-Maldonado ML; Poovathingal SK; Heintz S; Satheesh SV; Brattespe J; Xu J; Suster M; Skupin A; Esguerra CV
    Epilepsia; 2020 Mar; 61(3):549-560. PubMed ID: 32096222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome.
    Wengert ER; Wagley PK; Strohm SM; Reza N; Wenker IC; Gaykema RP; Christiansen A; Liau G; Patel MK
    Brain Res; 2022 Jan; 1775():147743. PubMed ID: 34843701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo SCN1A pathogenic variants in the GEFS+ spectrum: Not always a familial syndrome.
    Myers KA; Burgess R; Afawi Z; Damiano JA; Berkovic SF; Hildebrand MS; Scheffer IE
    Epilepsia; 2017 Feb; 58(2):e26-e30. PubMed ID: 28084635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome.
    Goff KM; Goldberg EM
    Elife; 2019 Jul; 8():. PubMed ID: 31282864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.